BVI to launch new SERENITY and SERENITY Toric monofocal IOLs

News
Article

The new, non-diffractive IOLs are the second generation of BVI’s ISOPURE premium monofocal IOL that was launched in 2019.

Doctor performing cataract surgery Image credit: AdobeStock/Kate

Image credit: AdobeStock/Kate

Ophthalmic device company BVI has announced that its new SERENITY and SERENITY Toric premium monofocal IOLs will be fully commercial available in CE-accepting markets in 2025.1 The new, non-diffractive IOLs are the second generation of BVI’s ISOPURE premium monofocal IOL that was launched in 2019, according to a news release.

“As we launch the second-generation SERENITY and SERENITY Toric IOLs, BVI views this IOL as potentially a game-changer when it comes to standard of care for monofocal procedures,” said Shervin Korangy, president and CEO of BVI, in the release. “Our portfolio includes a wide range of IOLs, meticulously designed from material to haptics to optics to provide the optimal outcome without the burden of retro-fitting legacy predicate devices.”

The IOL also features ISOFOCAL optic technology to aid in clear distance vision and intermediate vision by balancing depth of focus and image quality. This allows the lens to provide far vision equal to a monofocal but with adequate intermediate vision up to 66 cm. Additionally, the lens’ double c-loop POD platform is specifically designed to deliver precise astigmatism correction and stable IOL positioning, according to the release. Those with astigmatism benefit with stability in the capsular bag, which results in outcomes accurately predicted by BVI’s toric calculator.1

The SERENITY series’ ISOFOCAL technology also works in favor of stability by delivering spherical aberration correction across the entire optic diameter and customizable levels of spherical aberration per dioptric power, the release said.

Sheraz Daya, MD, FACP, FACS, FRCS(Ed), FRCOphth, of Centre For Sight, UK, was 1 of the first surgeons to implant SERENITY. “It is wonderful to see this increased range of focus lens on the same platform as the Finevision with 4 C loop haptics,” he said in the release. “I look forward to the Toric version as well which I know will be very stable with no rotation.”

BVI plans to launch the new IOL during the 2024 European Society of Cataract and Refractive Surgeons meeting in Fira de Barcelona, Spain from September 6-10.

Reference:
  1. BVI to launch new SERENITY and SERENITY toric premium monofocal IOLs. News release. BVI. September 3, 2024. Accessed September 4, 2024. https://www.bvimedical.com/us/bvi-to-launch-new-serenity-and-serenity-toric-premium-monofocal-iols/

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
© 2025 MJH Life Sciences

All rights reserved.